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INTRODUCTION
Karenia brevis is a marine dinoflagellate responsible for red tides that form almost
annually in late summer and autumn in the Gulf of Mexico and the Caribbean, and
can be carried on ocean currents to the east coast of the United States as far north as
North Carolina. K. brevis produces potent toxins called brevetoxins which contain a
number of different components including hemolytic, cardiotoxic, and neurotoxic
compounds (Kirkpatrick, 2004). The effects ofneurotoxic shellfish poisoning as a
result of consuming whole, contaminated fish or bivalves which concentrate the toxins
in their tissues (Sellner et al., 2003) are seen in many marine animals, and these toxins
were responsible for a large die-off of dolphins in 2004 (Naar et al., 2007) . Because
people in the United States do not generally consume fish in their entirety, deaths due
to neurotoxic shellfish poisoning from the consumption of fish are rarely documented in
people in this country (Naar et al., 2007) .
Even if they are not consumed, brevetoxins can have detrimental effects on the
health of marine animals and humans. These toxins, particularly PbTx-3, can be
aerosolized when the fragile organism is broken open in the crashing waves near the
shoreline and can be carried inland on wind and attached to salt particles, causing
respiratory irritation when inhaled. The mechanism by which brevetoxin exerts its effect
on the respiratory system is believed to be the result of the opening of voltage gated
sodium channels on nerve cell membranes. Brevetoxin induces contraction of the lower
airway smooth muscle by stimulation of the cholinergic nerve fiber sodium channels
with acetylcholine release. Additional pathways, such as mast cell degranulation, are also
thought to play a role in respiratory dysfunction. As a result of exposure, individuals
have reported an acute onset of conjunctiva! irritation, cattarrhal exudates, rhinorrhea,
nonproductive cough, bronchoconstriction, and other symptoms such as dizziness,
tunnel vision, and skin rashes. Furthermore, some researchers have postulated that in
addition to these acute effects ofbrevetoxin exposure, chronic effects such as chronic
neuro-intoxication, hemolytic anemia, and/or immunologic compromise may also occur
in humans and has been documented in chronically exposed manatees (Kirkpatrick,
2004).
While much information has been collected about the effects of brevetoxin
ingestion in contaminated seafood, there has been very little research conducted and
little is known about the effects of these toxins when inhaled in aerosols (Backer et al.,
2003 ). The effects of brevetoxins are of great public health concern because not only
are harmful algal blooms increasing in frequency and duration of occurrence, they are
also expanding their area of distribution (Sellner et al., 2003; Kirkpatrick, 2004 ). Since
a significant proportion of the world's population live within 75 miles of an ocean
coast and this density of human coastal populations is increasing daily, particularly in
subtropical and tropical areas (Fleming et al. , 2006), this puts many people at risk for

S4

International Journal of Global Health and Health Disparities

Published by UNI ScholarWorks, 2009

1

International Journal of Global Health and Health Disparities, Vol. 6, No. 1 [2009], Art. 7
suffering from respiratory ailments, particularly those individuals that have already been
diagnosed with respiratory disease such as asthma.
The purpose of this research paper is to review literature on the epidemiologic
relationship between aerosolized brevetoxin exposure during red tide events in Florida
and the development of respiratory related ailments, particularly in those individuals
that may be at increased risk due to preexisting respiratory conditions such as asthma,
chronic obstructive pulmonary disease, smoking, and degenerative disease in the elderly.

REVIEW OF LITERATURE
Four prospective cohort studies were conducted in Florida to examine the effects of
aerosolized brevetoxin exposure on pulmonary function. The first two studies examined
healthy individuals exposed at Florida beaches, and the second two studies examined
visitors to these beaches that had been previously diagnosed with asthma by a physician.
The first prospective cohort study by Backer et al. (2003) was conducted during two
separate Florida red tide events to assess whether beach-goers exposed to aerosolized
brevetoxins reported adverse health symptoms and experienced measurable changes
in lung function (spirometry) tests after spending time on the beach. The studies took
place at two different beaches, one in Sarasota on the Gulf coast of Florida in February
1999, and one in Jacksonville on the northeast coast of Florida in October 1999. A
total of 129 subjects were evaluated. The subjects at the Sarasota beach were unlikely
to be exposed because the red tide remained offshore and there was little wind. The
subjects in Jacksonville were likely to be exposed because strong onshore winds were
present and capable of carrying aerosolized toxins onto the beach. During both studies,
questionnaires were administered (including questions about demographics, pulmonary
health history, amount of time spent on the beach, medications, information about
potential confounders, and various symptoms), nose and throat swabs were collected
to evaluate potential biological markers of exposure (infiltration of inflammatory cells,
presence of epithelial cells, and immunohistochemical analysis of brevetoxin within
cells), and pulmonary function tests by spirometry were conducted. These evaluations
were conducted on visitors both before and after they spent time on the beach.
Environmental samples were also collected to determine the concentration of Karenia
brevis cells in seawater and the ambient air.
Of the study participants, 38% admitted to having allergies, 5.4% had been
diagnosed with asthma by a physician, 10% had suffered from some kind of pulmonary
disease including emphysema or bronchitis, 31 % were current smokers and 22.5%
were former smokers. Compared with those with low exposure to brevetoxins, those
with medium or high exposure reported more symptoms associated with both upper
respiratory irritation (e.g. eye irritation, nasal congestion, throat irritation, and cough)
and lower respiratory irritation (e.g. chest tightness, wheezing, shortness of breath).
Since few subjects from the nonexposed group reported increased respiratory symptoms,
it is highly unlikely that exposure to sea spray and sand alone were responsible for
the significant changes seen in the exposed group. There were no clinically important
changes in the spirometry parameters in any of the groups.
In Jacksonville, nose and throat swabs were collected from 41 highly exposed and
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On the high exposure day, 2.5% had a marked increase, 5% had moderate increases,
and 42% had mild increases in inflammatory response after exposure. On the moderate
exposure day, no one had a marked increase, 10% had moderate increases, and 29%
had mild increases in inflammatory response after exposure. A total of 49% and 39% of
people sampled on the high and moderate exposure days, respectively, had an increase
in inflammation in the nose and/or throat swab sample. The predominant inflammatory
response was acute to subacute, and primarily neutrophils were observed in the samples .
Twenty swab samples were immunohistochemically examined for the presence of
brevetoxin: 65% of pre- and post-exposure samples were negative, 10% were negative in
the pre-exposure and positive in the post-exposure samples, and 25% were negative in
the pre-exposure and equivocal in the post-exposure samples.
There were a number of variables in this study that may have had an effect on the
results. For instance, the different times of the year (February vs. October) made it
likely that other variables may be present; nasal swabs were only taken from individuals
at the Jacksonville beach and it is likely that the swabbing itself was irritating enough to
cause an inflammatory response; Jacksonville was hotter and less humid than Sarasota
during the studies; offshore winds in Sarasota changed to onshore later in the afternoon
but the levels of detectable brevetoxins in the air was low; participants spent anywhere
from ten minutes to eight hours at the beach and the averages for the time spent on the
beach differed with the degree of exposure to brevetoxins; and not everyone successfully
completed the spirometry tests. Aside from these factors, though, this was the first study
of its kind to compare the effects of aerosolized brevtoxins on the respiratory system,
and it provided a good baseline for future studies to further analyze the effects of these
toxins.
The second prospective cohort study conducted by Backer et al. ( 2005) looked
at 28 full-time healthy lifeguards on various beaches in Florida that are occasionally
affected by red tide. Subjects were subjected to spirometric pulmonary function tests
and symptom surveys which included questions about upper respiratory symptoms (i.e.,
eye and throat irritation, nasal congestion, cough) and lower respiratory symptoms (i.e.,
chest tightness, wheezing, shortness of breath) both before and after working a 6-8
hour shift both during times of red tide (exposure) and not (unexposed) . Environmental
samples of sea water and air were analyzed for the presence and levels of brevetoxins and
compared with subject results to confirm exposed/unexposed status.
The lifeguards were first interviewed using a questionnaire comprising questions
about demographics and pulmonary health history. These factors were then taken into
consideration when reviewing the results to rule out confounding factors. Exposure
status was determined separately for each individual lifeguard by day and by beach. This
was based on air sample analysis which corresponded with the air that the individual
lifeguards were exposed to since the instruments used to measure the brevetoxin levels
were located on the lifeguard towers near the lifeguards' breathing zones. This also
helped to rule out inconsistencies in the experimental design (wind speed and direction,
etc.). Because this study utilized self-reported symptom data, the possibility for the
study to suffer from reporting bias was apparent. The actual exposure status of the
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participants, though, was not known by the participants or the researchers at the time
of evaluation, and only became clear later when the environmental sample analysis was
completed .
Compared with nonexposure periods, the healthy lifeguards in the study reported
more upper airway but not lower airway discomfort during the red tide exposure
periods. There were statistically significant effects on some spirometry test parameters
during exposure to brevetoxins, but the changes were small and not clinically significant.
This study, therefore, suggested that, for healthy people, exposure to low levels of
brevetoxins in the air during Florida red tides is associated with temporary discomfort
in the form of respiratory irritation but is not associated with acute adverse effects on
pulmonary function.
This study used a fairly small sample size of healthy subjects. This is a difficult study
to control because subjects are exposed to natural environmental conditions which
cannot always be held constant. Overall the researchers did a nice job of interpreting the
results individually to avoid generalizations that may have not taken into consideration
the personal exposure of each lifeguard based on environmental variables. Also, it
is apparent that improvements were made in this study compared to the first one
previously discussed. The levels of brevetoxins present in the air were not as high as they
can sometimes get during red tide events, and it is interesting to note that even during
low levels of exposure by healthy individuals, respiratory irritation and discomfort is
experienced.
The third prospective cohort study conducted by Fleming et al. (2005) is very
similar to the two conducted by Backer et al., only this time fifty nine subjects with
physician-diagnosed asthma were evaluated for one hour before and after recreationally
visiting the beach on days with (exposed) and without (nonexposed) Florida red tide. In
addition to the spirometric pulmonary function tests and symptom surveys, the subjects
also had swabs taken from their nose and throat. This time participants were significantly
more likely to report respiratory symptoms after brevetoxin exposure and demonstrated
small but statistically significant decreases in forced expiratory volume in one second,
forced expiratory flow between 25-75%, and peak expiratory flow after exposure .
This was particularly true of individuals regularly using asthma medications. Similar
evaluations during nonexposure periods did not differ.
This study used similar techniques to the ones above to avoid confounding factors
and bias. Because there was a broader age range of subjects evaluated in this study, age
groups were evaluated as tertiles. Subjects were allowed to use their prescribed asthma
medications during the study, and this use was also taken into consideration during the
study analysis. The nose and throat swabs were an addition to the second study and
were used to evaluate the presence of inflammatory cells and protein transudation as a
result of the increased permeability of cell membranes due to the inflammatory process.
These swabs helped eliminate bias further since it was an additional objective test that
the subject did not have control over (as opposed to the symptom surveys) . A larger
sample size may have shown even larger differences between pre-and post-exposure to
brevetoxins.
A fourth prospective cohort study by Fleming et al. (2008), very similar to the one
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asthma. Ninety seven asthmatic subjects were evaluated by questionnaires, nasal swabs,
and spirometry after one hour at the beach both during times of red tide (exposure) and
without (nonexposure).
A baseline questionnaire was administered to collect information on possible
confounding factors, such as smoking, medication use, place of residence, etc.
Participants were examined separately in subpopulations by medication use prior to the
study period and by their geographic location of residence. Each participant underwent
at least three reproducible spirograms before and after visiting the beach to avoid the
possibility of an error with the readings. During this study more precise equipment and
diagnostics had been developed, including an individual personal sampler for aerosolized
toxins which measures 12 L/min instead of the previous 2 L/min. There was also a new
ELISA developed to determine the presence of breve toxins in the air samples.
The mean spirometry values after one hour of exposure were uniformly decreased
in comparison with values during nonexposure periods. Symptoms, predominantly
chest tightness, for both the medication and residence groups were statistically
different during exposure periods, whereas no significant differences were found during
nonexposure periods. These symptoms were particularly great in participants who did
not use medications prior to their beach visit. Participants with more severe asthma
demonstrated more uniform and greater differences in spirometry values and started
with lower preexposure baseline values. In the study population, participants living
inland that did not use medication had higher preexposure baseline spirometry values
than the other three subpopulations. The authors suspected that persons living inland
may be less exposed on a regular basis to the aerosols of an active K. brevis bloom, even
though these aerosols have been measured more than one mile inshore from the coast.
The participants residing in coastal areas had a preexposure spirometry measurement
less than that of persons residing inland, suggesting that coastal residents are exposed
on a chronic basis before the one hour beach exposure, thus reacting less to the beach
exposure during the experimental period.
Experiments involving environmental exposures can be difficult to regulate, as a
large number of variables may be present. Aside from the bronchoconstricting toxins
produced by K. brevis, the organism also produces a natural inhibitor to the toxins
known as brevenol. Brevenol was also measured during these experiments, but it
is not known how great of an effect this substance has on counteracting the toxins
present in the aerosols. This study did a very good job at looking at many variables
and confounding factors to rule out inconsistencies in the design . Because each subject
served as their own control, this study seems reliable based on the data that was
reported.
A retrospective cohort study was conducted by Kirkpatrick, et al. (2006) to compare
the rates of emergency room (ER) visits to the Sarasota Memorial Hospital (SMH)
between two time periods; October 1 - December 31, 2001 when there was a red tide
and October 1 - December 31, 2002 when there was no red tide period in Sarasota,
Florida. SMH is the largest acute care facility in Sarasota County and serves 63.3%
of this county's population; it is also the closest facility to the coastline. The authors
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received access to anonymous medical data provided by the Decision Support Services at
SMH. The Phytoplankton Ecology Program at Mote Marine Laboratory provided data
on the red tide cell counts.
ER admission data were collected from the same months in 2001 (red tide period)
and 2002 (non-red tide period) to minimize the effects of variation from respiratory
exacerbations or reactions from seasonal exposures, such as pollen, molds, or dander.
Since Sarasota has a seasonal population, the same three month period was used to
adjust for the fluxes in the population as most seasonal residents have the same visitation
pattern year after year. The study data consisted of the ER admission diagnosis with
the international classification of diseases (ICD) diagnosis classification for respiratory
disease and all other ICD diagnoses, the patient age, the residence zip code, and the
date of admission . The residence zip code was used to break up the subjects into
two groups: coastal residents and inland residents. The following mutually exclusive
respiratory disease primary diagnoses were selected for the study: pneumonia, bronchitis,
asthma, and upper airway disease. These four respiratory diagnoses accounted for 9192% of all respiratory diagnoses of ER admissions reported during the study months. All
other diagnoses were grouped as "all other primary diagnoses" .
The overall number of ER admissions during the 2001 and 2002 periods were
similar, as were the ages, gender distribution, and race distribution of the ER patients.
Of the respiratory diagnoses, pneumonia, bronchitis, asthma, and upper airway disease
comprised 92% of respiratory related ER admissions in 2001 and 91 % in 2002. When
ER admission rates were adjusted for age, the overall admission rates for all diagnoses
were similar for the red tide period and the non-red tide period. When the respiratory
ER admission rates were adjusted based on residence (coastal: < 1.6 km of shore;
inland: > 1.6 km of shore), though, residents living in the coastal area had a statistically
significantly increased ER admission rate compared to the inland residents during the
red tide period. However, when examined by subcategory of diagnosis, there was a nonsignificant increase in the admission rate for coastal residents during the red tide period
compared to their admission rates during the non-red tide period.
During the red tide period, there was a small increase in the risk of having an ER
admission for any respiratory diagnosis for coastal residents when compared with the risk
for inland residents. There was also an increased risk for ER admission for pneumonia
and upper airway disease during the red tide period for coastal residents compared to
inland residents. These increases, though, were not statistically significant. Interestingly,
during the non -red tide period, the inland residents had an increase in ER admissions for
respiratory diagnosis compared to coastal residents. The authors speculated that other
inland environmental triggers for respiratory symptoms may have been the cause for this.
Since the data in the study demonstrated increased rates of more chronic respiratory
illnesses such as bronchitis and pneumonia for people living in coastal areas during red
tide blooms, this may be reason to suspect that brevetoxins have a more lasting effect
on the respiratory system than the transient response associated with aerosolized toxins.
These chronic effects would be consistent with findings in manatees and laboratory
rodents. The authors suggest that although the cause of respiratory disease may be
infectious in nature, chronic exposure to aerosolized brevetoxins may be responsible
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There were a number oflimitations with this study. For instance, no individual
exposure information was collected for this analysis, and therefore the study only
reports an association of exposure with the time periods selected . Repeated admissions
by the same patient could not be identified and removed, nor could latency periods or
underlying predisposing health conditions be determined. No other health assessments
were made to explore other patterns that might have affected the increase in specific
respiratory admissions in 2001, such as an early influenza season. The zip codes reported
as place of residence do not necessarily identify the actual location of Florida red tide
exposure, nor do they document that exposure actually occurred. Florida population
for the year 2000 was used; however, age rate ratios based on the years 2001 and 2002
were used with a 95% confidence interval. It is not clear whether analysis accounted for
the possible increase in the population in 2002 compared with 2001 which may have
affected the number of admissions to the ER. P values were greater than 0.05, and thus
not statistically significant in most cases. Sample sizes were small and the confidence
intervals were wide indicating a considerable amount of variability in the data.
Overall, this study was a good preliminary analysis to determine the possible link
between brevetoxin exposure and chronic respiratory ailments. However, more specific
studies would need to be conducted to make any definitive conclusions regarding this
link.

SUMMARY AND CONCLUSIONS
The research being conducted on the effects of aerosolized brevetoxin exposure
and respiratory irritation and dysfunction in people is still in the developing stages.
All of the epidemiological studies conducted so far have been done by the same group
of researchers. Nonetheless, the negative effects of such exposures are apparent.
Experimental research conducted by Abraham (2005a, 20056) on asthmatic sheep
as models for human disease have clearly shown a relationship between brevetoxins
and respiratory dysfunction. There are numerous reports by beach-goers and coastal
residents, though most are anecdotal, of irritation to the respiratory tract and difficulty
breathing during times of red tide (Fleming, Backer, Baden, 2005 ). Due to the nature of
the exposures to these toxins, and the numerous variables that environmental conditions
can have on exposures, such as wind speed and direction, wave activity, and humidity,
controlling for these variables during systematic studies is difficult. As more and more
research is conducted on this subject, though, a more precise link between exposure to
brevetoxins and the effects this has on respiration will surely be identified, especially if
larger groups of subjects are utilized to obtain more statistically significant results . This
will have a great impact on the public health of coastal and inland areas of Florida, and
more appropriate control measures for the protection of public health, particularly for
individuals already suffering from respiratory ailments, can be implemented.
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